Ipsen Delivers Strong Results In 2025, Driven By Solid Execution Across All Therapeutic Areas, And Provides 2026 Guidance. <li /> FY 2025 sales growth of 10.9% at CER1, or 8.1% as reported, driven by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results